Integrated Diagnostics Holdings plc (LON:IDHC – Get Free Report) shares reached a new 52-week low during trading on Thursday. The stock traded as low as GBX 0.45 and last traded at GBX 0.46, with a volume of 71,464 shares. The stock had previously closed at GBX 0.46.
Integrated Diagnostics Stock Performance
The company has a market capitalization of £2.67 million, a PE ratio of 0.00, a P/E/G ratio of 7.65 and a beta of 0.44. The stock’s 50-day simple moving average is GBX 0.52 and its 200 day simple moving average is GBX 0.56. The company has a debt-to-equity ratio of 42.91, a quick ratio of 0.75 and a current ratio of 1.67.
Integrated Diagnostics Company Profile
IDH is a leading diagnostics services provider in the Middle East and Africa offering a broad range of clinical pathology and
radiology tests to patients in Egypt, Jordan, Nigeria, Saudi Arabia, and Sudan. The Group’s core brands include Al Borg, Al Borg
Scan and Al Mokhtabar in Egypt, as well as Biolab (Jordan), Echo-Lab (Nigeria), Ultralab and Al Mokhtabar Sudan (both in Sudan),
and Biolab KSA (Saudi Arabia). With over 40 years of experience, a long track record for quality and safety has earned the Company
a trusted reputation, as well as internationally recognised accreditations for its portfolio of over 3,000 diagnostics tests.
See Also
- Five stocks we like better than Integrated Diagnostics
- Google’s Credit Backstop May Be TeraWulf’s Biggest Advantage
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch
- Qualcomm Beat Earnings, But Its Fastest-Growing Businesses Have a Catch
- Oil, Uranium, or Renewables? 3 Energy Plays for a Changing Market
Receive News & Ratings for Integrated Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integrated Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
